Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03089476

Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy

Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
National Jewish Health · Academic / Other
Sex
All
Age
34 Weeks – 50 Years
Healthy volunteers
Accepted

Summary

It is hypothesized that food allergy is preceded by atopic dermatitis (AD), due to a disruption of skin barrier which can predispose one to food sensitization through the skin. The central hypothesis is that increased transepidermal water loss (TEWL) assessment and skin tape strip analysis (STS) of lipid and filaggrin breakdown products will be predictive markers for the development of AD. Additionally, the associated changes in TEWL and STS will further improve the identification of infants at risk of early food sensitization, compared to family history alone.

Conditions

Interventions

TypeNameDescription
OTHEREvaluating atopy in infantsThis study does not have an intervention. There is the evaluation of the predictive value of TEWL and STS in atopic infants at risk of developing eczema and TEWL and STS in parents of infants.
OTHEREvaluating TEWL and STS in adultsThis study does not have an intervention. There is the evaluation of the predictive value of TEWL and STS in atopic infants at risk of developing eczema and TEWL and STS in parents of infants.

Timeline

Start date
2017-09-30
Primary completion
2018-07-30
Completion
2018-07-30
First posted
2017-03-24
Last updated
2018-06-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03089476. Inclusion in this directory is not an endorsement.